Optimize PRO Study

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to collect clinical evidence on valve performance and procedural outcomes associated with an "optimized" TAVR care pathway and post-TAVR conduction disturbance pathway while using the Evolut™ PRO and Evolut™ PRO+ devices. The purpose of the addendum is to collect post-market clinical evidence on valve performance and procedural outcomes associated with the Evolut FX Device.

Clinical Trial Description

This is a post market, multi-center (sites in US/CAN/EMEA/ANZ), prospective, non-randomized study. The addendum is a post market, multi-center (sites in US only), prospective, non-randomized study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04091048
Study type	Observational
Source	Medtronic Cardiovascular
Contact
Status	Active, not recruiting
Phase
Start date	September 16, 2019
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03003650` - ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval Cohort	N/A
Completed	`NCT03314857` - China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population	N/A
Withdrawn	`NCT03247465` - Image Fusion and Calcification Raising in Trans Aortic Valve Implantation	N/A
Completed	`NCT03143686` - ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)
Active, not recruiting	`NCT05182307` - DurAVR™ THV System: First-In-Human Study	N/A
Active, not recruiting	`NCT03466918` - China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population	N/A
Completed	`NCT01819181` - Women's INternational Transcatheter Aortic Valve Implantation Registry
Completed	`NCT04331145` - Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation	Phase 4
Recruiting	`NCT02803294` - Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population	Phase 4
Completed	`NCT02536196` - The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation	N/A
Recruiting	`NCT04861805` - Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System	N/A
Withdrawn	`NCT02088021` - Assessment of the St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access	N/A
Terminated	`NCT02759237` - The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS)	N/A
Recruiting	`NCT01794832` - Severe Aortic Stenosis in Patients Referred for Valve Surgery	N/A
Completed	`NCT02424370` - Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation
Completed	`NCT01493284` - Portico TAVI Implant With Transfemoral Delivery System	N/A
Active, not recruiting	`NCT05712161` - Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study	N/A
Completed	`NCT02664649` - Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis	Phase 3
Completed	`NCT01487330` - First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System	N/A
Active, not recruiting	`NCT04722250` - SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial	N/A